RecruitingNCT06758960

Analysis of Biological Progression and Regression of HELLP Syndrome in Time

Biological Evolution of HELLP Syndrome


Sponsor

CHU Mohammed VI Marrakech

Enrollment

70 participants

Start Date

Jul 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective observational study about progression and regression of biological parameters of HELLP syndrome


Eligibility

Sex: FEMALE

Inclusion Criteria1

  • Pregnant women who are admitted to the maternal ICU for a biological HELLP syndrome

Exclusion Criteria2

  • Patients whose biological presentation was attributable to other conditions, such as microangiopathies or leukemia.
  • Patients who benefited from plasma exchange therapy

Locations(1)

CHU Mohammed VI of Marrakech

Marrakesh, Marrakech - Safi, Morocco

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06758960


Related Trials